News

Travelers over 60 advised to seek safer //vaccination alternatives . Individuals aged 60 and above are now being urged not to ...
How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after infection clears.
A warning has been issued by the Epidemiology Unit of the Ministry of Health regarding the potential spread of Chikungunya in ...
The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...
The Chikungunya outbreak in the country has not been declared as an epidemic situation by the Health Ministry, Health ...
The political parties and independent groups that won the recent local authorities’ election are scrambling to form ...
CHIKV can trigger long-term joint pain that mimics autoimmune diseases like rheumatoid arthritis, potentially due to ...
Leading virologist Dr. Neelika Malavige yesterday said that Sri Lanka was currently facing the worst chikungunya outbreak in ...
The EMA now advises against using the drug for people aged over 65 after 17 serious adverse effects were recorded in this age ...
Vantage with Palki Sharma | N18G Dengue and chikungunya, once tropical diseases, may soon become endemic in Europe due to climate change. The invasive tiger mosquito, which transmits both viruses, is ...
A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.
The number of cases of dengue and chikungunya in the country are continuing to rise steadily according to current data, ...